Point of Care (PoC) Molecular Diagnostics Market Size By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Apr 2021  |  Report ID: GMI2210  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 165   |   Base Year: 2020




Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    LATAM

1.2.5    MEA

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Point of care molecular diagnostics industry 3600 synopsis, 2016 – 2027 (USD Million)

2.1.1    Business trends

2.1.2    Technology trends

2.1.3    Application trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Point of Care (PoC) Molecular Diagnostics Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016- 2027 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing incidence of infectious diseases

3.3.1.2    Increasing R&D funding to reduce time required for molecular diagnostic tests

3.3.1.3    Growing awareness about pre-disease diagnostics to control occurrence of diseases

3.3.1.4    Technological advancements in DNA sequencing and analysis

3.3.2    Industry pitfalls and challenges

3.3.2.1    Long product development time

3.3.2.2    Complex regulatory process

3.4    Growth potential analysis

3.4.1    By technology

3.4.2    By application

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Technology landscape

3.7    All in one diagnostics solutions overview

3.7.1    Companies operating in all-in-one diagnostic

3.7.2    Major end-user types

3.8    Porter’s analysis

3.9    Competitive landscape, 2020

3.9.1    Company matrix analysis, 2020

3.10    PESTEL analysis

Chapter 4   Point of Care (PoC) Molecular Diagnostics Market, By Technology

4.1    Key segment trends

4.2    Polymerase Chain Reaction (PCR)

4.2.1    Market size, by region, 2016 - 2027 (USD Million)

4.3    In Situ Hybridization

4.3.1    Market size, by region, 2016 - 2027 (USD Million)

4.4    Sequencing

4.4.1    Market size, by region, 2016 - 2027 (USD Million)

4.5    Isothermal amplification

4.5.1    Market size, by region, 2016 - 2027 (USD Million)

4.6    Others

4.6.1    Market size, by region, 2016 - 2027 (USD Million)

Chapter 5   Point of Care (PoC) Molecular Diagnostics Market, By Application

5.1    Key segment trends

5.2    Infectious disease

5.2.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.2    Flu

5.2.2.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.3    Respiratory Syncytial Virus (RSV)

5.2.3.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.4    Tuberculosis

5.2.4.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.5    HIV

5.2.5.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.6    Gonorrhea

5.2.6.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.7    Chlamydia

5.2.7.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.8    Hepatitis C

5.2.8.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.9    Hepatitis B

5.2.9.1    Market size, by region, 2016 - 2027 (USD Million)

5.2.10    Others

5.2.10.1    Market size, by region, 2016 - 2027 (USD Million)

5.3    Oncology

5.3.1    Market size, by region, 2016 - 2027 (USD Million)

5.4    Hematology

5.4.1    Market size, by region, 2016 - 2027 (USD Million)

5.5    Others

5.5.1    Market size, by region, 2016 - 2027 (USD Million)

Chapter 6   Point of Care (PoC) Molecular Diagnostics Market, By End-use

6.1    Key segment trends

6.2    Hospitals

6.2.1    Market size, by region, 2016 – 2027 (USD Million)

6.3    Clinics

6.3.1    Market size, by region, 2016 – 2027 (USD Million)

6.4    Others

6.4.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 7   Point of Care (PoC) Molecular Diagnostics Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size, by country, 2016 – 2027 (USD Million)

7.2.2    Market size, by technology, 2016 – 2027 (USD Million)

7.2.3    Market size, by application, 2016 – 2027 (USD Million)

7.2.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.2.5    U.S.

7.2.5.1    Market size, by technology, 2016 – 2027 (USD Million)

7.2.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.2.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.2.6    Canada

7.2.6.1    Market size, by technology, 2016 – 2027 (USD Million)

7.2.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.2.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3    Europe

7.3.1    Market size, by country, 2016 – 2027 (USD Million)

7.3.2    Market size, by technology, 2016 – 2027 (USD Million)

7.3.3    Market size, by application, 2016 – 2027 (USD Million)

7.3.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.5    Germany

7.3.5.1    Market size, by technology, 2016 – 2027 (USD Million)

7.3.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.6    UK

7.3.6.1    Market size, by technology, 2016 – 2027 (USD Million)

7.3.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.7    France

7.3.7.1    Market size, by technology, 2016 – 2027 (USD Million)

7.3.7.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.8    Italy

7.3.8.1    Market size, by technology, 2016 – 2027 (USD Million)

7.3.8.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.8.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.9    Spain

7.3.9.1    Market size, by technology, 2016 – 2027 (USD Million)

7.3.9.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.9.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.10    Russia

7.3.10.1    Market size, by technology, 2016 – 2027 (USD Million)

7.3.10.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.10.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4    Asia Pacific

7.4.1    Market size, by country, 2016 – 2027 (USD Million)

7.4.2    Market size, by technology, 2016 – 2027 (USD Million)

7.4.3    Market size, by application, 2016 – 2027 (USD Million)

7.4.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.5    Japan

7.4.5.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.6    China

7.4.6.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.7    India

7.4.7.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.7.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.8    Australia

7.4.8.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.8.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.8.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.9    South Korea

7.4.9.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.9.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.9.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.10    Malaysia

7.4.10.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.10.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.10.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.11    Thailand

7.4.11.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.11.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.11.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.12    Vietnam

7.4.12.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.12.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.12.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.13    Philippines

7.4.13.1    Market size, by technology, 2016 – 2027 (USD Million)

7.4.13.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.13.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.5    Latin America

7.5.1    Market size, by country, 2016 – 2027 (USD Million)

7.5.2    Market size, by technology, 2016 – 2027 (USD Million)

7.5.3    Market size, by application, 2016 – 2027 (USD Million)

7.5.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.5.5    Mexico

7.5.5.1    Market size, by technology, 2016 – 2027 (USD Million)

7.5.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.5.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.5.6    Brazil

7.5.6.1    Market size, by technology, 2016 – 2027 (USD Million)

7.5.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.5.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.5.7    Argentina

7.5.7.1    Market size, by technology, 2016 – 2027 (USD Million)

7.5.7.2    Market size, by application, 2016 – 2027 (USD Million)

7.5.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6    Middle East and Africa

7.6.1    Market size, by country, 2016 – 2027 (USD Million)

7.6.2    Market size, by technology, 2016 – 2027 (USD Million)

7.6.3    Market size, by application, 2016 – 2027 (USD Million)

7.6.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.5    South Africa

7.6.5.1    Market size, by technology, 2016 – 2027 (USD Million)

7.6.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.6.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.6    Saudi Arabia

7.6.6.1    Market size, by technology, 2016 – 2027 (USD Million)

7.6.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.6.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.7    Nigeria

7.6.7.1    Market size, by technology, 2016 – 2027 (USD Million)

7.6.7.2    Market size, by application, 2016 – 2027 (USD Million)

7.6.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.8    Egypt

7.6.8.1    Market size, by technology, 2016 – 2027 (USD Million)

7.6.8.2    Market size, by application, 2016 – 2027 (USD Million)

7.6.8.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.9    Morocco

7.6.9.1    Market size, by technology, 2016 – 2027 (USD Million)

7.6.9.2    Market size, by application, 2016 – 2027 (USD Million)

7.6.9.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.10    UAE

7.6.10.1    Market size, by technology, 2016 – 2027 (USD Million)

7.6.10.2    Market size, by application, 2016 – 2027 (USD Million)

7.6.10.3    Market size, by end-use, 2016 – 2027 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard, 2020

8.2    Abbott Laboratories

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    BioMérieux SA

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    Bio-Rad Laboratories, Inc

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    Danaher Corporation

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    Sysmex Corporation

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    Abaxis Inc

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Mesa Biotech (Thermo Fisher Scientific)

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9.    Roche Diagnostics

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    OraSure Technologies, Inc

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    VIRCELL S.L

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

 

Data Tables

TABLE 1. Global PoC molecular diagnostics market, 2016 - 2027 (USD Million)

TABLE 2. PoC molecular diagnostics market, by technology, 2016 - 2027 (USD Million)

TABLE 3. Global PoC molecular diagnostics market, by application, 2016 - 2027 (USD Mn)

TABLE 4. Global PoC molecular diagnostics market, by end-use, 2016 - 2027 (USD Mn)

TABLE 5. Global PoC molecular diagnostics market, by region, 2016 - 2027 (USD Million)

TABLE 6. Industry impact forces

TABLE 7. Some of the major players in ‘all-in-one’ diagnostics industry

TABLE 8. PCR market size, by region, 2016 - 2027 (USD Million)

TABLE 9. In Situ Hybridization market size, by region, 2016 - 2027 (USD Million)

TABLE 10.      Sequencing market size, by region, 2016 - 2027 (USD Million)

TABLE 11.      Isothermal amplification market size, by region, 2016 - 2027 (USD Million)

TABLE 12.      Others market size, by region, 2016 - 2027 (USD Million)

TABLE 13.      Infectious disease market size, by region, 2016 - 2027 (USD Million)

TABLE 14.      Flu market size, by region, 2016 - 2027 (USD Million)

TABLE 15.      RSV market size, by region, 2016 - 2027 (USD Million)

TABLE 16.      Tuberculosis market size, by region, 2016 - 2027 (USD Million)

TABLE 17.      HIV market size, by region, 2016 - 2027 (USD Million)

TABLE 18.      Gonorrhea market size, by region, 2016 - 2027 (USD Million)

TABLE 19.      Chlamydia market size, by region, 2016 - 2027 (USD Million)

TABLE 20.      Hepatitis C market size, by region, 2016 - 2027 (USD Million)

TABLE 21.      Hepatitis B market size, by region, 2016 - 2027 (USD Million)

TABLE 22.      Others market size, by region, 2016 - 2027 (USD Million)

TABLE 23.      Oncology market size, by region, 2016 - 2027 (USD Million)

TABLE 24.      Hematology testing market size, by region, 2016 - 2027 (USD Mn)

TABLE 25.      Others market size, by region, 2016 - 2027 (USD Million)

TABLE 26.      Hospitals market size, by region, 2016 - 2027 (USD Million)

TABLE 27.      Clinics market size, by region, 2016 - 2027 (USD Million)

TABLE 28.      Others market size, by region, 2016 - 2027 (USD Million)

TABLE 29.      North America market size, by country, 2016 - 2027 (USD Million)

TABLE 30.      North America market size, by technology, 2016 - 2027 (USD Million)

TABLE 31.      North America market size, by application, 2016 - 2027 (USD Million)

TABLE 32.      North America market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 33.      North America market size, by end-use, 2016 - 2027 (USD Million)

TABLE 34.      U.S. market size, by technology, 2016 - 2027 (USD Million)

TABLE 35.      U.S. market size, by application, 2016 - 2027 (USD Million)

TABLE 36.      U.S. market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 37.      U.S. market size, by end-use, 2016 - 2027 (USD Million)

TABLE 38.      Canada market size, by technology, 2016 - 2027 (USD Million)

TABLE 39.      Canada market size, by application, 2016 - 2027 (USD Million)

TABLE 40.      Canada market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 41.      Canada market size, by end-use, 2016 - 2027 (USD Million)

TABLE 42.      Europe market size, by country, 2016 - 2027 (USD Million)

TABLE 43.      Europe market size, by technology, 2016 - 2027 (USD Million)

TABLE 44.      Europe market size, by application, 2016 - 2027 (USD Million)

TABLE 45.      Europe market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 46.      Europe market size, by end-use, 2016 - 2027 (USD Million)

TABLE 47.      Germany market size, by technology, 2016 - 2027 (USD Million)

TABLE 48.      Germany market size, by application, 2016 - 2027 (USD Million)

TABLE 49.      Germany market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 50.      Germany market size, by end-use, 2016 - 2027 (USD Million)

TABLE 51.      UK market size, by technology, 2016 - 2027 (USD Million)

TABLE 52.      U.K. market size, by application, 2016 - 2027 (USD Million)

TABLE 53.      U.K. market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 54.      UK market size, by end-use, 2016 - 2027 (USD Million)

TABLE 55.      France market size, by technology, 2016 - 2027 (USD Million)

TABLE 56.      France market size, by application, 2016 - 2027 (USD Million)

TABLE 57.      France market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 58.      France market size, by end-use, 2016 - 2027 (USD Million)

TABLE 59.      Italy market size, by technology, 2016 - 2027 (USD Million)

TABLE 60.      Italy market size, by application, 2016 - 2027 (USD Million)

TABLE 61.      Italy market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 62.      Italy market size, by end-use, 2016 - 2027 (USD Million)

TABLE 63.      Spain market size, by technology, 2016 - 2027 (USD Million)

TABLE 64.      Spain market size, by application, 2016 - 2027 (USD Million)

TABLE 65.      Spain market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 66.      Spain market size, by end-use, 2016 - 2027 (USD Million)

TABLE 67.      Russia market size, by technology, 2016 - 2027 (USD Million)

TABLE 68.      Russia market size, by application, 2016 - 2027 (USD Million)

TABLE 69.      Russia market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 70.      Russia market size, by end-use, 2016 - 2027 (USD Million)

TABLE 71.      Asia Pacific market size, by country, 2016 - 2027 (USD Million)

TABLE 72.      Asia Pacific market size, by technology, 2016 - 2027 (USD Million)

TABLE 73.      Asia Pacific market size, by application, 2016 - 2027 (USD Million)

TABLE 74.      Asia Pacific market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 75.      Asia Pacific market size, by end-use, 2016 - 2027 (USD Million)

TABLE 76.      Japan market size, by technology, 2016 - 2027 (USD Million)

TABLE 77.      Japan market size, by application, 2016 - 2027 (USD Million)

TABLE 78.      Japan market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 79.      Japan market size, by end-use, 2016 - 2027 (USD Million)

TABLE 80.      China market size, by technology, 2016 - 2027 (USD Million)

TABLE 81.      China market size, by application, 2016 - 2027 (USD Million)

TABLE 82.      China market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 83.      China market size, by end-use, 2016 - 2027 (USD Million)

TABLE 84.      India market size, by technology, 2016 - 2027 (USD Million)

TABLE 85.      India market size, by application, 2016 - 2027 (USD Million)

TABLE 86.      India market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 87.      India market size, by end-use, 2016 - 2027 (USD Million)

TABLE 88.      South Korea market size, by technology, 2016 - 2027 (USD Million)

TABLE 89.      South Korea market size, by application, 2016 - 2027 (USD Million)

TABLE 90.      South Korea market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 91.      South Korea market size, by end-use, 2016 - 2027 (USD Million)

TABLE 92.      Malaysia market size, by technology, 2016 - 2027 (USD Million)

TABLE 93.      Malaysia market size, by application, 2016 - 2027 (USD Million)

TABLE 94.      Malaysia market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 95.      Malaysia market size, by end-use, 2016 - 2027 (USD Million)

TABLE 96.      Thailand market size, by technology, 2016 - 2027 (USD Million)

TABLE 97.      Thailand market size, by application, 2016 - 2027 (USD Million)

TABLE 98.      Thailand market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 99.      Thailand market size, by end-use, 2016 - 2027 (USD Million)

TABLE 100.    Vietnam market size, by technology, 2016 - 2027 (USD Million)

TABLE 101.    Vietnam market size, by application, 2016 - 2027 (USD Million)

TABLE 102.    Vietnam market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 103.    Vietnam market size, by end-use, 2016 - 2027 (USD Million)

TABLE 104.    Philippines market size, by technology, 2016 - 2027 (USD Million)

TABLE 105.    Philippines market size, by application, 2016 - 2027 (USD Million)

TABLE 106.    Philippines market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 107.    Philippines market size, by end-use, 2016 - 2027 (USD Million)

TABLE 108.    Australia market size, by technology, 2016 - 2027 (USD Million)

TABLE 109.    Australia market size, by application, 2016 - 2027 (USD Million)

TABLE 110.    Australia market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 111.    Australia market size, by end-use, 2016 - 2027 (USD Million)

TABLE 112.    Latin America market size, by country, 2016 - 2027 (USD Million)

TABLE 113.    Latin America market size, by technology, 2016 - 2027 (USD Million)

TABLE 114.    Latin America market size, by application, 2016 - 2027 (USD Million)

TABLE 115.    Latin America market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 116.    Latin America market size, by end-use, 2016 - 2027 (USD Million)

TABLE 117.    Brazil market size, by technology, 2016 - 2027 (USD Million)

TABLE 118.    Brazil market size, by application, 2016 - 2027 (USD Million)

TABLE 119.    Brazil market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 120.    Brazil market size, by end-use, 2016 - 2027 (USD Million)

TABLE 121.    Mexico market size, by technology, 2016 - 2027 (USD Million)

TABLE 122.    Mexico market size, by application, 2016 - 2027 (USD Million)

TABLE 123.    Mexico market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 124.    Mexico market size, by end-use, 2016 - 2027 (USD Million)

TABLE 125.    Argentina market size, by technology, 2016 - 2027 (USD Million)

TABLE 126.    Argentina market size, by application, 2016 - 2027 (USD Million)

TABLE 127.    Argentina market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 128.    Argentina market size, by end-use, 2016 - 2027 (USD Million)

TABLE 129.    MEA market size, by country, 2016 - 2027 (USD Million)

TABLE 130.    MEA market size, by technology, 2016 - 2027 (USD Million)

TABLE 131.    MEA market size, by application, 2016 - 2027 (USD Million)

TABLE 132.    MEA market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 133.    MEA market size, by end-use, 2016 - 2027 (USD Million)

TABLE 134.    South Africa market size, by technology, 2016 - 2027 (USD Million)

TABLE 135.    South Africa market size, by application, 2016 - 2027 (USD Million)

TABLE 136.    South Africa market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 137.    South Africa market size, by end-use, 2016 - 2027 (USD Million)

TABLE 138.    Nigeria market size, by technology, 2016 - 2027 (USD Million)

TABLE 139.    Nigeria market size, by application, 2016 - 2027 (USD Million)

TABLE 140.    Nigeria market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 141.    Nigeria market size, by end-use, 2016 - 2027 (USD Million)

TABLE 142.    Egypt market size, by technology, 2016 - 2027 (USD Million)

TABLE 143.    Egypt market size, by application, 2016 - 2027 (USD Million)

TABLE 144.    Egypt market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 145.    Egypt market size, by end-use, 2016 - 2027 (USD Million)

TABLE 146.    Morocco market size, by technology, 2016 - 2027 (USD Million)

TABLE 147.    Morocco market size, by application, 2016 - 2027 (USD Million)

TABLE 148.    Morocco market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 149.    Morocco market size, by end-use, 2016 - 2027 (USD Million)

TABLE 150.    Saudi Arabia market size, by technology, 2016 - 2027 (USD Million)

TABLE 151.    Saudi Arabia market size, by application, 2016 - 2027 (USD Million)

TABLE 152.    Saudi Arabia market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 153.    Saudi Arabia market size, by end-use, 2016 - 2027 (USD Million)

TABLE 154.    UAE market size, by technology, 2016 - 2027 (USD Million)

TABLE 155.    UAE market size, by application, 2016 - 2027 (USD Million)

TABLE 156.    UAE market size, by infectious disease, 2016 - 2027 (USD Million)

TABLE 157.    UAE market size, by end-use, 2016 - 2027 (USD Million)

 

Charts & Figures

FIG. 1 Top-down approach

FIG. 2 Data validation

FIG. 3 Point of care molecular diagnostics industry 3600 synopsis

FIG. 4 Industry segmentation

FIG. 5 Global PoC molecular diagnostics market, 2016 - 2027 (USD Million)

FIG. 6 Stages of new invitro diagnostic product development

FIG. 7 Growth potential analysis, by technology

FIG. 8 Growth potential analysis, by application

FIG. 9 Growth potential analysis, by end-use

FIG. 10  Potential addressable end-users of all in one diagnostic solutions

FIG. 11  Porter’s analysis

FIG. 12  Company matrix analysis, 2020

FIG. 13  PESTEL analysis

FIG. 14  Key segment trends, by technology

FIG. 15  Key segment trends, by application

FIG. 16  Key segment trends, by end-use

FIG. 17  Key regional trends

FIG. 18  Competitive dashboard, 2020

 

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Premium Report Details

  • Published Date: Apr 2021
  • Pages: 165
  • Tables: 157
  • Charts / Figures: 18
  • Companies covered: 10
  • Countries covered: 26

Get a report that explains COVID-19 impact on this market, request a free sample now

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X